G3BP1 and nasopharyngeal carcinoma: Univariate survival analysis, conducted via the log-rank test, revealed significantly lower OS rates for NPC patients exhibiting high expression of G3BP1 proteins in both label group and result group (p = 0.044 and p = 0.037, label group and result group, respectively.